- In April 2024, Dr. Reddy’s launched Nerivio, a drug-free, noninvasive device for migraine management. Supported by the company's M-free patient support program, this device aims to enhance the patient experience with services including onboarding, counseling, device demonstrations, doorstep delivery, flexible payment plans, educational content, and dedicated customer support.
- In January 2023, PENTAX Medical received CE marks for its new premium video processor, the PENTAX Medical INSPIRA, and the i20c video endoscope series. This new processor is compatible with PENTAX Medical's latest endoscope models and introduces new standards for high-quality imaging.
- In August 2023, Orthofix Medical announced the full commercial launch of their 7D Flash navigation system percutaneous module 2.0 in the U.S.. This enhanced version adds new planning features and broadens the utility of the 7D Flash neuronavigation system for minimally invasive spinal surgeries. The 7D system was originally provided by 7D Surgical, which was acquired by SeaSpine in 2021 after the merger between Orthofix and SeaSpine earlier this year.
- In October 2022, scientists from Imperial College London successfully implanted a new bioinspired, flexible, and steerable device into the brains of living animals using a minimally invasive robotic system for the first time. This advanced platform offers high precision and less intrusive procedures and could potentially improve the detection and treatment of diseases in humans if proven safe and effective.
- In June 2022, Boston Scientific entered into an agreement to acquire a majority stake in M.I.Tech, a South Korean manufacturer and distributor of non-vascular metal stents used for endoscopic and urologic procedures. The deal was valued at approximately USD 230 million, with Boston Scientific paying about approximately USD 11 per M.I.Tech share.
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Surgical Devices, Monitoring and Visualization Devices, and Endoscopy Devices), Surgery Type (Endonasal Neurosurgery, Intracranial, Spinal Surgery, and others), End Use (Hospital, Clinics, Medical Institution, and Ambulatory Surgical Center) – Industry Trends and Forecast to 2032
.
The Global Minimally Invasive Neurosurgical Devices Market size was valued at USD 2.00 USD Billion in 2024.
The Global Minimally Invasive Neurosurgical Devices Market is projected to grow at a CAGR of 6.02% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
